Senores Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Senores Pharmaceuticals Ltd. on BSE

Load latest

Senores Pharmaceuticals Ltd.

22 Apr 2025

620.00

1.23%

Company Update

Senores Pharmaceuticals Ltd - 544319 - Update In Respect Of Our Intimations Dated March 11, 2025 …

BSE India

Senores Pharmaceuticals Limited has informed the Exchange regarding the Update in respect of intimations dated March 11, 2025 and March 12, 2025.

pdf

Senores Pharmaceuticals Ltd.

19 Apr 2025

620.00

1.23%

Company Update

Senores Pharmaceuticals Ltd - 544319 - Intimation For Change In Contact Details Of MUFG Intime India …

BSE India

Senores Pharmaceuticals Limited has informed the Exchange regarding change in contact details of MUFG Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company.

pdf

Senores Pharmaceuticals Ltd.

04 Apr 2025

620.00

1.23%

Company Update

Senores Pharmaceuticals Ltd - 544319 - Intimation For Change In Corporate Identity Number (CIN) And Listing …

BSE India

Senores Pharmaceuticals Limited has informed the Exchange that pursuant to listing of the equity shares of the Company, the Corporate Identity Number (CIN) and Listing Status have been updated in the master data maintained by Ministry of Corporate Affairs(MCA).

pdf

Senores Pharmaceuticals Ltd.

03 Apr 2025

620.00

1.23%

Company Update

Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Senores Pharmaceuticals Limited has informed the Exchange Schedule of Analyst/Investor meeting on April 09, 2025.

pdf

Senores Pharmaceuticals Ltd.

03 Apr 2025

620.00

1.23%

Company Update

Senores Pharmaceuticals Ltd - 544319 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Senores Pharmaceuticals Limited has informed the Exchange about certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025.

pdf

Senores Pharmaceuticals Ltd.

02 Apr 2025

620.00

1.23%

Company Update

Senores Pharmaceuticals Ltd - 544319 - Announcement Under Regulation 30 Of Securities And Exchange Board Of …

BSE India

Senores Pharmaceuticals Limited has informed the Exchange about giving corporate guarantee for credit facilities availed by Ratnatris Pharmaceuticals Private Limited , a material subsidiary, from HDFC Bank Limited.

pdf

Senores Pharmaceuticals Ltd.

27 Mar 2025

620.00

1.23%

SAST

Senores Pharmaceuticals Ltd - 544319 - Closure of Trading Window

BSE India

Senores Pharmaceuticals Limited has informed the Exchange regarding the Closure of Trading Window.

pdf

Senores Pharmaceuticals Ltd.

20 Mar 2025

620.00

1.23%

Company Update

Senores Pharmaceuticals Ltd - 544319 - Intimation Under Regulation 30(6) Of SEBI (LODR) Regulations, 2015.

BSE India

Senores Pharmaceuticals Limited has informed the Exchange regarding investment through rights issue in Senores Pharmaceuticals Inc., Wholly Owned Subsidiary of the Company.

pdf

Senores Pharmaceuticals Ltd.

12 Mar 2025

620.00

1.23%

Company Update

Senores Pharmaceuticals Ltd - 544319 - Additional Disclosure In Respect Of Our Intimation Dated March 11, …

BSE India

Senores Pharmaceuticals Limited has informed the Exchange about the additional disclosure in respect of our intimation dated March 11, 2025.

pdf

Senores Pharmaceuticals Ltd.

11 Mar 2025

620.00

1.23%

Company Update

Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Senores Pharmaceuticals Limited has informed the Exchange regarding acquisition of 8454 equity shares of Havix Group Inc. D/B/A Aavis Pharmaceuticals subsidiary of the Company.

pdf

RESEARCH REPORTS

SEE REPORTS >

pdf